Swedish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

fibromyalgia/kräkning

Länken sparas på Urklipp
Sida 1 från 36 resultat
This 14-week, phase 3, double-blind, randomized, controlled trial evaluated sodium oxybate (SXB) 4.5 and 6g per night versus placebo in patients with fibromyalgia (FM). SXB is the sodium salt of γ-hydroxybutyrate (GHB). GHB is an endogenous compound, synthesized from γ-aminobutyric acid (GABA) and

Sodium oxybate therapy provides multidimensional improvement in fibromyalgia: results of an international phase 3 trial.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND Fibromyalgia is characterised by chronic musculoskeletal pain and multiple symptoms including fatigue, multidimensional function impairment, sleep disturbance and tenderness. Along with pain and fatigue, non-restorative sleep is a core symptom of fibromyalgia. Sodium oxybate (SXB) is
BACKGROUND The long-term safety and therapeutic response of sodium oxybate (SXB) in fibromyalgia syndrome (FM) patients were assessed for a combined period of up to 1 year in a prospective, multicenter, open-label, extension study in patients completing 1 of 2 phase 3 randomized, double-blind,

A 1-year safety and efficacy study of duloxetine in patients with fibromyalgia.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
OBJECTIVE Evaluate the efficacy and safety of duloxetine at doses up to 120 mg once daily in patients with fibromyalgia. METHODS This was a phase 3, 60-week study, which included an 8-week open-label period followed by a 52-week, randomized, double-blind period. Patients received duloxetine 30 mg

Preliminary experience using milnacipran in patients with juvenile fibromyalgia: lessons from a clinical trial program.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND There are no approved medications for juvenile fibromyalgia (JFM), a disorder that is often under-diagnosed. The effects of milnacipran, a drug approved for the management of fibromyalgia (FM) in adults, was assessed in a clinical trial program for JFM. METHODS Patients, ages 13-17 years

Prevalence of functional gastrointestinal disorders in patients with fibromyalgia and the role of psychologic distress.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
OBJECTIVE Fibromyalgia is a rheumatologic disorder associated with somatic and psychologic conditions. Although fibromyalgia is associated with irritable bowel syndrome, its relationship with other functional gastrointestinal disorders (FGID) is unclear. We evaluated the prevalence of FGID in

Monoamine oxidase inhibitors (MAOIs) for fibromyalgia syndrome.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND Fibromyalgia (FM) syndrome is a chronic condition of unknown aetiology characterised by musculoskeletal pain that often co-exists with sleep disturbance, cognitive dysfunction and fatigue. Patients often report high disability levels and poor quality of life. Since there is no specific
Fibromyalgia syndrome is a chronic multifaceted disease characterized by widespread pain, muscle stiffness, fatigue, unrefreshing sleep and cognitive disorders. To date, no medication has been shown to significantly improve pain, associated symptoms and Quality of Life in fibromyalgic

Increased frequency of gastrointestinal symptoms in patients with fibromyalgia and associated factors: a comparative study.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
OBJECTIVE To determine the frequency and severity of gastrointestinal (GI) symptoms in patients with fibromyalgia (FM). METHODS We included 152 women with FM (mean age 45.4 +/- 12.2 yrs), 98 women with rheumatoid arthritis (RA; mean age 45.5 +/- 12.3 yrs), and 60 healthy female controls (mean age 44

The promise of substance P inhibitors in fibromyalgia.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
The discovery of SP and its potent biological activities have lead to the discovery of other tachykinins and to receptors for them, including the NK1 receptor. Blockade of the NK1 receptor has a number of potentially beneficial effects in medical care including the management of drug-induced emesis

Diurnal and twenty-four hour patterning of human diseases: acute and chronic common and uncommon medical conditions.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
The symptom intensity and mortality of human diseases, conditions, and syndromes exhibit diurnal or 24 h patterning, e.g., skin: atopic dermatitis, urticaria, psoriasis, and palmar hyperhidrosis; gastrointestinal: esophageal reflux, peptic ulcer (including perforation and hemorrhage), cyclic

Substance P and Substance P receptor antagonists in the pathogenesis and treatment of affective disorders.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Substance P (SP) is a neuropeptide which is widely distributed in the periphery and the central nervous system (CNS), where it is co-localised with other neurotransmitters such as serotonin or dopamine and where it acts as a neuromodulator. SP has been proposed to play a role in the aetiopathology

Droperidol analgesia for opioid-tolerant patients.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND Patients with acute and chronic pain syndromes such as migraine headache, fibromyalgia, and sickle cell disease represent a significant portion of emergency department (ED) visits. Certain patients may have tolerance to opioid analgesics and often require large doses and prolonged time in

A commentary on the medicinal use of marijuana.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Lately, the number of people using marijuana in the USA has dramatically increased. In 2018, many states have legalized marijuana use for both medical and recreational purposes, thus exploring the evidence behind medical marijuana use became essential. Muslim majority countries enforce

5-HT3 receptors.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
5-HT(3)-receptor antagonists are highly selective competitive inhibitors of the 5-HT(3)-receptor with negligible affinity for other receptors. They are potent, rapidly absorbed and easily penetrate the blood-brain barrier; metabolized by the cytochrome P450-system with half-life varying from 3-10
Gå med på vår
facebook-sida

Den mest kompletta databasen med medicinska örter som stöds av vetenskapen

  • Fungerar på 55 språk
  • Växtbaserade botemedel som stöds av vetenskap
  • Örter igenkänning av bild
  • Interaktiv GPS-karta - märka örter på plats (kommer snart)
  • Läs vetenskapliga publikationer relaterade till din sökning
  • Sök efter medicinska örter efter deras effekter
  • Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent

Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning

Google Play badgeApp Store badge